Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Acute × camrelizumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 5 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Nasopharyngeal Carcinoma 2 Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Pancreatic Neoplasms 1 Mouth Neoplasms 1 Lung Neoplasms 1 Laryngeal Neoplasms 1 Gestational Trophoblastic Disease 1 Esophageal Squamous Cell Carcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Biliary Tract Carcinoma 1

Interventions

venetoclax 87 Azacitidine 69 Cytarabine 52 fludarabine 43 Specimen Handling 36 Biopsy 26 Daunorubicin 25 Cyclophosphamide 25 Decitabine 24 fludarabine phosphate 22 Injections 19 Granulocyte Colony-Stimulating Factor 18 Busulfan 17 Whole-Body Irradiation 16 Stem Cell Transplantation 15 Idarubicin 15 Mycophenolic Acid 14 Melphalan 14 Tacrolimus 13 CPX-351 13 gilteritinib 11 decitabine and cedazuridine drug combination 11 Filgrastim 11 enasidenib 9 ivosidenib 8 Mitoxantrone 8 Methotrexate 8 Magnetic Resonance Spectroscopy 8 Gemtuzumab 8 Cladribine 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡